by Stacey Johnson | Feb 7, 2014
. Science communications – #scicomm for you Twitter fans – is an important aspect of what we do here at Signals Blog and even rates its own category. Science communications aims to educate the public (and sometimes scientists) about a science-related topic. A variety...
by Mark Curtis | Feb 4, 2014
. Welcome to your Update from the Clinic for the month of January! We start the year off with the German health authority approving Pluristem’s next generation GMP cell manufacturing facility. Neuralstem successfully, and safely, transplants NSI-556 cells directly...
by Lisa Willemse | Jan 31, 2014
> By now, most readers will be familiar with this week’s announcement of a remarkable new discovery that mouse cells were made pluripotent using a relatively simple and quick acid bath technique. For those who aren’t, there’s reams of coverage,...
by Stacey Johnson | Jan 24, 2014
. My colleague, Casandra Gardner, PhD, was excited when she came across the image, below, of a plastic cell. Since my understanding of polymers is limited to what my university chem-eng boyfriend taught me many (many!) years ago, I thought Casey would do a much better...
by Ben Paylor | Jan 21, 2014
> “I resolve to not get any older.” This may seem like a somewhat outlandish New Year’s resolution, a desire more grounded in the realm of science fiction than science itself. But a growing group working in the field of biogerontology would argue that it is...
by Lisa Willemse | Jan 17, 2014
> If you’ve ever wondered what makes a stem cell hasten its way down the mutational road to cancer, wonder no more. The answer is revenge – a kind of adolescent rebellion against parental (the body’s) and evoloutionary control. At least...
by Sara M. Nolte | Jan 15, 2014
> I have recently been transitioning from “basic” science research to science communication. Why? Because there is a great disparity in what the public, policy makers, and even clinicians, know and think about research, and what the researchers know. I believe as...
by Mark Curtis | Jan 13, 2014
. Welcome to your Regenerative Medicine Deal Review for the month of December. Toronto-based Stem Cell Therapeutics successfully executed on a financing of $33 million, while Pluristem announces it is moving forward on a licensing agreement with Korea-based CHA....
by Lisa Willemse | Jan 10, 2014
> Earlier this week, we tweeted some articles published online at Scientific American that provide some perspectives on the complexity and high costs of drug discovery – so far, two have been published, here and here. The tweet elicited a thought-provoking...
by Paul Krzyzanowski | Jan 9, 2014
> If your morning cup of coffee wasn’t enough to wake you up today, researchers from the New York Stem Cell Foundation and Columbia University just reported being able to generate iPS cells from human brain tissue that’s been frozen for 11 years:...
Comments